Innokin Issues Product Recall Notice for Kroma Nova Model

Business by 2FIRSTS

May.20.2024

Innokin Issues Product Recall Notice for Kroma Nova Model

Innokin issues recall notice for all Kroma Nova products due to safety concerns with unique charging solution components.

Recently, the official website of Innokin has issued a product recall notice for the Kroma Nova.

The contents of the announcement are as follows:

We would like to inform you that the INNOKIN Kroma Nova product is now being recalled. This recall covers all production batches of the Kroma Nova. The Kroma Nova uses a unique charging solution that requires special components specifically designed for this model. Unfortunately, the components from the supplier are defective and may pose a safety risk.

In order to ensure customer safety and maintain high standards for our products, we have decided to issue a precautionary recall for the INNOKIN Kroma Nova.

Innokin is proud of its high safety standards and complete transparency with customers. We encourage all Innokin customers to contact us at any time when they encounter issues so that our team can promptly address them.

Customer: Please contact us at support@innokin.com for further details on the recall process. Enterprise customers: Please contact your sales representative.

References:

[1] IMPORTANT CONSUMER SAFETY INFORMATION

Also Read:

[1] Innokin: Conductive Ceramics to Transform E-cigarettes

[2] Innokin Faces 337 Investigation by Reynolds: Ready to Respond to Lawsuit

[3] Innokin Partners with Bahrain Duty Free for Product Expansion

#Europe #Open system e-cigarettes #Spain #Major companies #Product

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

Hounslow Crackdown Seizes £33,000 of Illegal Vapes and Combustible Cigarettes

Hounslow Council’s Trading Standards team, working with Metropolitan Police units, conducted test purchases across the borough and found seven premises selling illegal tobacco. Subsequent raids at 16 premises in Chiswick, Feltham and Hounslow High Street seized 4,859 illegal vapes (≈£30,000), 3,806 combustible cigarettes (≈£3,000), 16kg of shisha and 11kg of chewing tobacco. Offences included oversized tanks, over-strength nicotine, and unregistered products.

Oct.22 by 2FIRSTS.ai

South Korea’s National Assembly Passes Law Classifying E-Cigarettes as Tobacco Products with Full Equivalent Regulation

South Korea’s National Assembly recently passed a comprehensive package of 79 bills that, among other measures, formally classifies liquid vapes — e-cigarette products using nicotine-containing e-liquids — as tobacco products. These products will now be subject to the same taxation, sales restrictions and advertising controls as traditional cigarettes, and the vaping industry in South Korea is expected to face significant adjustments in compliance costs, market access and business strategy.

Dec.03

PMI Japan Upgrades IQOS ILUMA i One with New Button Layout, Aluminum Base

PMI Japan has refreshed its all-in-one heated tobacco device, IQOS ILUMA i One, with upgraded materials and exterior design. Sales begin October 29 via IQOS stores and the official website. The new model retains core features such as auto-start and continuous use, but is not compatible with accessories from the previous version.